文献速递妇科

医院手术量对早期宫颈癌手术治疗及结局的影响

Impact of hospital volume on surgical management and outcomes for early-stage cervical cancer.
PubMed 文献 · Gynecol Oncol · 2020-02-21

基于美国国家癌症数据库2011-2013年3469例IA2-IB1期宫颈癌患者,按医院年子宫切除量四分位分组,比较手术方式、淋巴结评估、NCCN依从手术及生存。高手术量医院更常行根治性子宫切除和淋巴结评估,指南依从手术率更高,但5年生存无差异,医院手术量非死亡独立预测因子。

要点

  • 高手术量医院根治性子宫切除率68.9% vs 低手术量59.6%,淋巴结评估率96.1% vs 87.3%。
  • 高手术量医院NCCN依从手术率67.8% vs 低手术量56.4%,差异有统计学意义。
  • 医院手术量与5年生存、90天生存及全因死亡率无关,非死亡独立预测因子。

核心结论

  • 高手术量医院早期宫颈癌患者接受NCCN推荐手术的比例更高,但医院手术量与生存无关联。

研究设计与样本

  • 回顾性队列研究,利用美国国家癌症数据库纳入2011-2013年IA2-IB1期宫颈癌女性3469例,分布于598家医院。
  • 按医院前一年子宫切除量计算年手术量并分为患者水平四分位,最高四分位为高手术量中心,最低为低手术量中心。

主要发现

  • 高手术量医院根治性子宫切除率68.9%,低手术量医院59.6%(p<0.001)。
  • 高手术量医院淋巴结评估率96.1%,低手术量医院87.3%(p<0.001)。
  • 高手术量医院指南依从手术率67.8%,低手术量医院56.4%,高11.4%(p<0.001)。
  • 年龄≥80岁、Medicaid和Medicare保险、西班牙裔种族及低分化组织学为死亡独立预测因子;医院手术量非死亡独立预测因子(p=0.95)。

关键数值与推荐

  • 高手术量医院指南依从手术率67.8% vs 低手术量56.4%(p<0.001)。
  • 高手术量医院根治性子宫切除率68.9% vs 低手术量59.6%(p<0.001)。
  • 高手术量医院淋巴结评估率96.1% vs 低手术量87.3%(p<0.001)。

临床怎么用

  • 早期宫颈癌手术应优先选择高手术量医院以提高NCCN指南依从手术率。
  • 医院手术量可作为手术质量过程指标的参考,但不应单独用于预测生存。

局限性

  • 原文未报告局限性内容。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine whether process and outcome measures varied for patients with early-stage cervical cancer based on hospital surgical volume. METHODS: Using the National Cancer Database, we identified women with stages IA2 - IB1 cervical cancer (2011-2013). Annual hospital volume was calculated using number of hysterectomies performed in the prior year and grouped into patient level-quartiles. Centers in the highest quartile of volume were defined as HVCs; those in the lowest quartile, as LVCs. Demographics, type/mode of hysterectomy, lymph node assessment, NCCN-compliant surgery (radical hysterectomy (RH) with LND), and survival outcomes were compared across quartiles of hospital volume. Cox Proportional Hazards model was performed to determine impact of volume on mortality. RESULTS: We identified 3469 women treated at 598 different hospitals. RH was more likely at HVCs versus LVCs (68.9% vs. 59.6%, p < 0.001). LND was more likely at HVCs versus LVCs (96.1% vs 87.3%, p < 0.001). Patients treated at HVCs were 11.4% more likely to receive guideline-compliant surgery compared to LVCs (67.8% vs. 56.4%, p < 0.001). There was no difference in 5-year survival, 90-day survival, all-cause mortality across volume quartiles. Thirty-day mortality was significantly lower at HVCs (0 deaths in 880 patients) versus LVCs (1 in 1058 (0.1%, p = 0.02)). Age ≥ 80, Medicaid and Medicare insurance, Hispanic race, and poorly differentiated histology were independent predictors of mortality. Hospital volume was not found to be an independent predictor of mortality (p = 0.95). CONCLUSIONS: HVCs demonstrated higher rates of NCCN-recommended surgery for early-stage cervical cancer. There was no association between hospital volume and survival.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Aviki EM, Chen L, Dessources K, et al. Impact of hospital volume on surgical management and outcomes for early-stage cervical cancer. Gynecol Oncol. 2020. PMID: 32089335. doi:10.1016/j.ygyno.2020.02.029

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。